Clinical Trial Update: Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase I/II clinical trial evaluating Tagraxofusp in combination with Decitabine for patients with chronic myelomonocytic leukemia and myelodysplastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Myeloproliferative Neoplasm
• Myelomonocytic Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Tagraxofusp (tagraxofusp)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING